Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Jerry Davis who wrote (1008)	1/6/1998 11:02:00 PM
From: EZLibra	Read Replies (1) \| Respond to of 3702

I heard the same thing. Selling could be from a 'better idea', other margin problems, fear and loathing in Tustin, whatever. Volume could be Nasdaq's normal passing of the buck. I don't think conversion will happen until an immediate profit can be realized, they did buy the science after all. The communication problems should be well on their way to being solved by this time next week.

To: Jerry Davis who wrote (1008)	1/7/1998 11:39:00 AM
From: shero	Respond to of 3702

This is a very good post and you accurately point out the real problem of the stock being this low. Its not realliy an issue of whether or not the shareholders are losing money but an issue of dilution. My understanding of the last financing is that to conversion price of the preffered is a discount off the median price of the stock during a certain "window" of time. I think the next window is between February and March, but someone else can elaborate better. I think you will see a focused, concerted effort to get this story out to investors. There is so much to say here that if the company had a good spokesperson with credibility this could easily be a 6 or 7 dollar stock.